|
Year
|
Technology Area(s)
|
Project Title
|
Sponsor/ Supporting Parties
|
Principle Investors
|
Fund Approved
|
Project Reference
|
|
2023
|
Chinese Medicine
|
Research and Development of a Novel Fermented Chinese Herbal Medicine for Combating Obesity and Its Associated Metabolic Disorders
|
Acaderma Asia Limited
|
Dr ZHAO Danyue
|
HK$ 2,999,890
(total funding)
|
ITS/040/22MS
|
|
2021
|
Biotechnology/ Chinese Medicine
|
基於腸菌轉化的天然抗骨質疏鬆先導化合物的發現
|
Increasepharm (HK) Ltd, Increasepharm (Tianjin) Institute Co., Ltd (Mainland Partner)
|
Prof. WONG Man Sau
|
HK$ 989,843
|
MHX/002/20
|
|
2021
|
Chinese Medicine
|
基于清热解毒类中药靶向LIF 通路的抗肿瘤创新药物发现
|
Dynamic Star Limited, Ling Nam Medicine Factory (H.K.) Limited, Chinese Pharmaceuticals (HK) Co. Limited, Tianjin University of Traditional Chinese Medicine (Mainland Partner), Gratia Bio Company Limited
|
Dr CHEN Sibao
|
HK$ 1,690,000
|
MHP/010/20
|
|
2021
|
Environmental Protection/ Biotechnology
|
Precision Manufacturing and Bioactivation of Artificial Reefs to Facilitate Coral Restoration
|
Shenzhen Institute of Guangdong Ocean University, AFCD, World Wide Fund for Nature Hong Kong, Shenzhen Dapeng New District Science Innovation and Economic Service Bureau, Hong Kong Marine Conservation Society, Shenzhen Institute of Guangdong Ocean University (Mainland Partner), World Wide Fund for Nature China, Guangzhou Society of Diving Enthusiasts, Hong Kong Underwater Association, Ocean Citizenship Limited
|
Dr FANG Kar Hei
|
HK$ 1,952,815
|
MHP/009/19
|
|
2020
|
Biotechnology
|
Development of Novel Fluorescent Probes for Detection of Aldehydes
|
New Life Medicine Technology Company Limited
|
Prof. WONG Man Kin
|
HK$ 500,000
|
PRP/075/19FX
|
|
2019
|
Electronics/
Nanotechnology and Materials Science
|
Research and Development of a Safe and Effective Herbal Drug for Postmenopausal Osteoporosis
|
Jinan University
Beijing HebaBiz Biotechnology Co., Ltd.
|
Prof. WONG Man Sau
|
HK$ 4,099,750
|
MRP/012/18X
|
|
2016
|
Biotechnology
|
Improving Meat Quality of Cultured Giant Grouper
|
Aquaculture Technologies Asia (R&D) Ltd. (Sponsor)
|
Dr KWOK Wing Hin Kevin Patrick
|
HK$ 807,960
|
ITS/078/15FX
|
|
2016
|
Chinese Medicine
|
Developing the Next-Generation Bone Protective Agent for Postmenopausal Women Using Cordyceps Sinensis
|
Hua Ming Xing Ye Biotechnology Ltd. (Sponsor)
|
Prof. WONG Ka Hing
|
HK$ 980,022
|
ITS/258/15FX
|
|
2015
|
Chinese Medicine
|
Development of Appropriate Classification for Testing of Hong Kong Chinese Materia Medica - Promoting Local Chinese Materia Medica Testing and Certification Industry
|
HKU, HKBU, CityU, CUHK, HKUST,
Hong Kong Chinese Medicine Merchants Association, Hong Kong Chinese Medicine Industry Association, CMA Testing and Certification Laboratories (Sponsor), SGS Hong Kong Limited (Sponsor), The Hong Kong Standards and Testing Centre Limited (Sponsor)
|
Dr MOK Kam Wah
|
HK$ 2,159,700
|
GSP/030/14
|
|
2014
|
Chinese Medicine/
Testing and Certification
|
Platform Development for Quality Control of Proprietary Chinese Medicine for Hong Kong with the Use of Chemometrics
|
HKUST, Eu Yan Sang (Hong Kong) Ltd (Sponsor), Poon Goor Soe Medicine Factory (Sponsor)
|
Dr MOK Kam Wah
|
HK$ 667,230
|
ITS/155/13FP
|
|
2013
|
Nanotechnology and Materials Science
|
Pilot Scale Production of a Novel, Safe and Evidence-based Selenium Nanoparticles Health Food Product Using Tiger Milk Mushroom
|
New Team International Enterprise Limited (Sponsor), Jinan University,
PolyU, Guangdong Institute of Microbiology- Guangdong Yuewei Edible Fungi Technology Co. Ltd.
|
Prof. WONG Ka Hing
|
HK$ 1,450,000
|
GHX/011/12NI
|
